What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
Many patients begin noticing improvements within 2-4 weeks of treatment
Questions To Ask Before Buying Syringes Before ordering syringes, confirm four details: medication format, syringe capacity, needle-attachment style, and whether a specific gauge or needle length is listed
The goal is not aggressive exercise programming but rather sustainable movement that preserves muscle, supports mood, and enhances overall results without adding stress to an already demanding time
The Phase 3 TRIUMPH-4 data pushed that even higher, to 28.7% at 68 weeks
135 , e202310178 (2023)
